Cellectis (CLLS) Change in Inventory (2015 - 2021)
Cellectis (CLLS) posted quarterly Change in Inventory of $289000.0 for Q4 2021, down 91.63% year-over-year from $3.5 million in Q4 2020, and down 63.51% quarter-over-quarter from $792000.0 in Q3 2021.
Cellectis (CLLS) Change in Inventory (2015 - 2021) Analysis & Trends
Cellectis' Change in Inventory history runs 7 years deep, the most recent figure standing at $289000.0 for Q4 2021.
- In Q4 2021, Change in Inventory fell 91.63% year-over-year to $289000.0; the TTM figure through Dec 2021 stood at $215000.0 (up 115.0% YoY), while the FY2021 annual figure was $215000.0, up 115.0% from the prior year.
- Change in Inventory for Q4 2021 stood at $289000.0, down from $792000.0 in the prior quarter.
- The five-year high for Change in Inventory was $3.5 million in Q4 2020, with the low at -$3.7 million in Q1 2021.
- The 5-year median for Change in Inventory is -$898.2 (2017), against an average of -$122889.8.
- Peak annual rise in Change in Inventory reached 953.57% in 2019, while the deepest fall reached 34328.57% in 2019.
- Cellectis' Change in Inventory stood at -$116000.0 in 2017, then surged by 51.72% to -$56000.0 in 2018, then soared by 953.57% to $478000.0 in 2019, then jumped by 622.38% to $3.5 million in 2020, then sank by 91.63% to $289000.0 in 2021.
- Business Quant data shows CLLS's Change in Inventory at $289000.0 in Q4 2021, $792000.0 in Q3 2021, and $2.9 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 289,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Jun 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Sep 30, 2020 | -540,000.00 |
| Sep 30, 2020 | -540,000.00 |
| Jun 30, 2020 | -2.11 Mn |
| Jun 30, 2020 | -2.11 Mn |
| Mar 31, 2020 | -702,000.00 |
| Mar 31, 2020 | -702,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Sep 30, 2019 | -2.40 Mn |
| Sep 30, 2019 | -2.40 Mn |